Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.58 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.58 |
| ▸ | CA1 | P00915 | 4/20 | 0.58 |
| ▸ | LPL | P06858 | 3/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.46 |
| ▸ | MGLL | Q99685 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.39 |
| ▸ | TUBB | P07437 | 1/20 | 0.39 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.39 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.39 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.39 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.39 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.39 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.39 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.39 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.39 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.39 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.39 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7777060 | 0.86 | TRPV6 (0.46) | CA2ENPP2CA1LPLLIPG | |
| SCHEMBL18059894 | 0.83 | CA1 (0.39) | CA2ENPP2CA1 | |
| SCHEMBL25968742 | 0.83 | CA2 (0.54) | CA2ENPP2CA1LPLLIPG | |
| SCHEMBL18245611 | 0.81 | SLC6A2 (0.37) | CA2ENPP2CA1 | |
| SCHEMBL27814632 | 0.81 | CA1 (0.42) | CA2ENPP2CA1 | |
| SCHEMBL26746 | 0.80 | SLC6A2 (0.44) | CA2CA1TSHRCA7CA14 | |
| SCHEMBL7360678 | 0.79 | CA2 (0.50) | CA2ENPP2CA1LPLLIPG | |
| SCHEMBL26464057 | 0.79 | CA2 (0.50) | CA2ENPP2CA1LPLLIPG | |
| SCHEMBL26464362 | 0.79 | CA2 (0.50) | CA2ENPP2CA1LPLLIPG | |
| SCHEMBL27233488 | 0.78 | CA2 (0.48) | CA2ENPP2CA1LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024016826-A1 | 6-POSITION SUBSTITUTED DIHYDROBENZO[E][1,2,3]OXATHIAZINE 2,2-DIOXIDE COMPOUND, PREPARATION THEREFOR, AND USE THEREOF | 杭州市第七人民医院 | 2024-01-25 | — | — | WO | claimed |
| CN-115232090-A | 6-substituted dihydrobenzo [ e ] [1,2,3] oxathiazine 2,2-dioxide compound and preparation and application thereof | 杭州市第七人民医院 | 2022-10-25 | — | — | CN | claimed |
| US-20250276509-A1 | ORGANIC LIGHT EMITTING DIODE DISPLAY | SAMSUNG DISPLAY CO LTD (KR) | 2025-09-04 | — | — | US | disclosed |
| EP-3521366-B1 | CURABLE MODIFIED PETROLEUM RESIN, AND PREPARATION METHOD AND USE THEREOF | KOLON INC (KR) | 2025-07-30 | — | — | EP | disclosed |
| WO-2025137345-A1 | CRYSTALLINE FORMS OF AN IMIDAZOPYRIDINE DERIVATIVE | ARISAN THERAPEUTICS INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| EP-3647333-B1 | CURABLE PETROLEUM RESIN, PREPARATION METHOD THEREFOR, AND USE THEREOF | KOLON INC (KR) | 2025-06-18 | — | — | EP | disclosed |
| US-12310224-B2 | Organic light emitting diode display | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-05-20 | — | — | US | disclosed |
| CN-119409549-A | Color light conversion material, color light conversion adhesive film and photovoltaic module | 上海住阳新能源科技有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-115232090-B | 6-Substituted dihydrobenzo [ e ] [1,2,3] oxathiazine 2, 2-dioxide compound and preparation and application thereof | 杭州市第七人民医院 | 2024-11-19 | — | — | CN | disclosed |
| US-20240298513-A1 | ORGANIC LIGHT EMITTING DIODE DISPLAY | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-09-05 | — | — | US | disclosed |
| CN-118406057-A | 4-Methylbenzamide compound and application thereof | 四川大学 | 2024-07-30 | — | — | CN | disclosed |
| EP-0865431-A2 | COMPOUNDS | Astra Pharmaceuticals Limited (GB) | 1998-09-23 | — | — | EP | disclosed |
| US-5723474-A | TREATING POST-MENOPAUSAL SYNDROME, UTERINE FIBROID DISEASE, ENDOMETRIOSIS, AND AORTAL SMOOTH MUSCLE CELL PROLIFERATION; ANTIESTROGENS | ELI LILLY AND COMPANY (US) | 1998-03-03 | — | — | US | disclosed |
| WO-1997020815-A1 | COMPOUNDS | ASTRA PHARMACEUTICALS LTD. (GB) | 1997-06-12 | — | — | WO | disclosed |
| EP-0729956-A1 | Benzothiophene compounds, intermediates, compositions, and methods | ELI LILLY AND COMPANY (US) | 1996-09-04 | — | — | EP | disclosed |
| US-5510357-A | POST-MENOPAUSAL SYNDROME, ENDOMETRIOSIS | ELI LILLY AND COMPANY (US) | 1996-04-23 | — | — | US | disclosed |
| US-5510358-A | OSTEOPOROSIS | ELI LILLY AND COMPANY (US) | 1996-04-23 | — | — | US | disclosed |
| US-5510498-A | Benzothiophene compounds, intermediates, compositions, and methods | ELI LILLY AND COMPANY (US) | 1996-04-23 | — | — | US | disclosed |
| US-5492922-A | PREVENTING RESTENOSIS | ELI LILLY AND COMPANY (US) | 1996-02-20 | — | — | US | disclosed |
| US-5488058-A | UROGENITAL DISORDERS OR OSTEOPOROSIS | ELI LILLY AND COMPANY (US) | 1996-01-30 | — | — | US | disclosed |